Evidence map›Paper›PMID 34044221›Full record

Observational studyEBioMedicine2021

Endotrophin is associated with chronic multimorbidity and all-cause mortality in a cohort of elderly women.

Line Mærsk Staunstrup, Cecilie Liv Bager, Peder Frederiksen, Jørn Wulff Helge, Søren Brunak, Claus Christiansen, Morten Karsdal

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in EBioMedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Clinical Insights from Proteomics in Heart Failure.Current heart failure reports · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Plasma endotrophin, reflecting tissue fibrosis, is associated with graft failure and mortality in KTRs: results from two prospective cohort studies.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Matrisome changes in Parkinson's disease.Analytical and bioanalytical chemistry · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Line Mærsk StaunstrupDepartment of Biomedical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark; Nordic Bioscience, DK-2730 Herlev, Denmark. Electronic address: lms@nordicbio.com.
Cecilie Liv BagerNordic Bioscience, DK-2730 Herlev, Denmark.
Peder FrederiksenNordic Bioscience, DK-2730 Herlev, Denmark.
Jørn Wulff HelgeCenter for Healthy Aging, Department of Biomedical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark.
Søren BrunakNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark.
Claus ChristiansenNordic Bioscience, DK-2730 Herlev, Denmark.
Morten KarsdalNordic Bioscience, DK-2730 Herlev, Denmark.
Nordic Bioscience (Denmark) · DKUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe signalling peptide endotrophin is derived through proteolytic cleavage of the carboxyl-terminal during formation of type VI collagen. It is expressed by most descendants of the mesenchymal stem cells lineage, including adipocytes and fibroblasts, and have been proposed to be a central extracellular matrix hormone associated with several age-related diseases. We aimed to assess the association of endotrophin with chronic disease incidence and death in older women.

methods5,602 elderly Danish women from the observational, prospective cohort: The Prospective Epidemiological Risk Factor (PERF) study were included in the analysis which covered baseline (BL) and follow-up (FU) 14 years later. An elastic net was used to investigate the relative importance of 58 variables to serum endotrophin-levels. 20 chronic diseases were defined on the basis of clinical variables available along with diagnoses extracted from both the National Patient Register, the National Diabetes Register and the Danish Cancer Registry. The cross-sectional associations between endotrophin-levels and these 17 chronic age-related diseases were investigated using logistic regression and a set-analysis explored disease-combinations within multimorbidity. The association of endotrophin with mortality was assessed by Cox proportional hazard models.

findingsFormation of type III collagen (PRO-C3), age and creatine-levels were the most influential variables of endotrophin-levels. Several chronic diseases were significantly associated with endotrophin-levels independent of age and BMI including chronic kidney disease (BL OR=3.7, p < 0.001; FU OR = 7.9 p < 0.001), diabetes (BL OR = 1.5, p = 0.0015, FU OR=1.6, p = 0.004) and peripheral arterial disease (BL OR = 1.3, p = 0.029; FU OR=2.4, p < 0.001). Lastly, endotrophin-levels were significantly rising with number of morbidities (p < 0.001) and a predictor of death after adjusting for age and BMI (BL HR=1.95; FU HR = 2.00).

interpretationEndotrophin was associated with death and increased with number of morbidities. Endotrophin may be a central hormone of fibroblast that warrant investigation and possible targeted intervention in several chronic diseases.

fundingThe funder of the PERF study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.

Indexed as

AgedAged, 80 and overAge FactorsCause of DeathChronic DiseaseCollagen Type IIICollagen Type VICreatinineCross-Sectional StudiesDenmarkFemaleHumansLogistic ModelsMiddle AgedMultimorbidityPeptide FragmentsCollagen Type IIICollagen Type VICreatinineendotrophinPeptide FragmentsChronic diseaseEndotrophinExtracellular matrix (ECM)FibrosisMultimorbidity

Identifiers

PMID34044221
PMCPMC8167215
OpenAlexW3163977336

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.